Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
0.7373
-0.0531 (-6.72%)
At close: Oct 15, 2026, 4:00 PM EDT
0.7350
-0.0023 (-0.31%)
After-hours: Oct 15, 2026, 7:49 PM EDT
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 6 employees as of June 30, 2026. The number of employees decreased by 2 or -25.00% compared to the same quarter last year. That makes Aldeyra Therapeutics the 41,220th largest employer in the world and 6,373rd in the United States.
Employees
6
Change
-2
Growth
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$3,842,123
Market Cap
44.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 6 | -2 | -25.00% |
| Mar 31, 2026 | 7 | -1 | -12.50% |
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Sep 30, 2025 | 8 | -1 | -11.11% |
| Jun 30, 2025 | 8 | -2 | -20.00% |
| Mar 31, 2025 | 8 | -2 | -20.00% |
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Sep 30, 2024 | 9 | -3 | -25.00% |
| Jun 30, 2024 | 10 | -5 | -33.33% |
| Mar 31, 2024 | 10 | -5 | -33.33% |
| Dec 31, 2023 | 10 | -5 | -33.33% |
| Sep 30, 2023 | 12 | -3 | -20.00% |
| Jun 30, 2023 | 15 | 1 | 7.14% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Sep 30, 2022 | 15 | 4 | 36.36% |
| Jun 30, 2022 | 14 | 4 | 40.00% |
| Mar 31, 2022 | 14 | 6 | 75.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 97 |
| Mereo BioPharma Group | 39 |
| Elicio Therapeutics | 33 |
| iBio, Inc. | 23 |
| ImageneBio | 18 |
| Werewolf Therapeutics | 14 |
| Apollomics | 14 |
| Alterity Therapeutics | 11 |
ALDX News
- 16 days ago - Aldeyra Therapeutics Transcript: FDA announcement - Transcripts
- 16 days ago - Aldeyra Therapeutics Press release: FDA announcement - Filings
- 16 days ago - Aldeyra Therapeutics Slides: FDA announcement - Filings
- 16 days ago - Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap - TheFly
- 16 days ago - Aldeyra sees operational cash runway into 2029 - TheFly
- 16 days ago - Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease - Business Wire
- 17 days ago - Aldeyra Therapeutics to Host Regulatory Update Webcast - Business Wire
- 2 months ago - Aldeyra Therapeutics Quarterly report: Q2 2026 - Filings